| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| setipiprant | prostaglandin d2 receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Asthma[MeSHID:D001249] |
2.45 | phase 3 | unknown |
| setipiprant | prostaglandin d2 receptor 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Asthma[MeSHID:D001249] |
5.3 | phase 3 | antagonist |
| setipiprant | prostaglandin d2 receptor 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Asthma[MeSHID:D001249] |
5.3 | phase 3 | unknown |
| click here to return to the previous page | ||||||||